Discover
SBRA
Sabra Health Care REIT, Inc.
19.68
2 x 14.05
2 x 25.34
bid
ask
+
0.17
0.87%
2 @ 04:00 PM
19.67 -0.01 (0.05%)
| Ytd | 3.91% | |
| 1y | 7.54% |
19.59
day range
19.77
17.17
52 week range
21.28
| Open | 19.63 | Prev Close | 19.51 | Low | 19.59 | High | 19.77 | Mkt Cap | 4.96B |
| Vol | 3.51M | Avg Vol | 2.70M | EPS | 0.63 | P/E | 31.24 | Forward P/E | 26.48 |
| Beta | 0.63 | Short Ratio | 9.41 | Inst. Own | 108.08% | Dividend | 1.20 | Div Yield | 6.15 |
| Ex Div Date | 05-15 | Earning | 04-29 | 50-d Avg | 19.74 | 200-d Avg | 19.31 | 1yr Est | 22.15 |
SBRA News
benzinga.com
Citigroup Downgrades Sabra Health Care REIT to Neutral, Lowers Price Target to $19
Citigroup analyst Nick Joseph downgrades Sabra Health Care REIT (NASDAQ:SBRA) from Buy to Neutral
benzinga.com
Scotiabank Maintains Sector Perform on Sabra Health Care REIT, Lowers Price Target to $19
Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Sector P
benzinga.com
Raymond James Reinstates Underperform on Sabra Health Care REITto Underperform
Raymond James analyst David Rodgers reinstates Sabra Health Care REIT (NASDAQ:SBRA) from Market P
benzinga.com
AbbVie, UnitedHealth, Sabra Health Care And A Consumer Defensive Stock On CNBC's 'Final Trades'
Coca-Cola is Kevin Simpson's final trade; AbbVie gets upgraded and Sabra Health Care and UnitedH
benzinga.com
Wells Fargo Maintains Overweight on Sabra Health Care REIT, Raises Price Target to $23
Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overwe